Action Alert: Protect Access to Compounded Peptides Federal regulators are making decisions right now that could determine the future of peptide based therapies in the U.S. Compounded peptides such as BPC 157 and epitalon The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and RFK Jr. & claimed regenerative peptides like BPC 157 The Niche FDA Peptide Update: Category 2 Removals Explained BPC 157: The peptide with big claims and scant evidence STAT People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian